HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J Levy Selected Research

Heart Valve Diseases (Valvular Heart Disease)

1/2022Poly-2-methyl-2-oxazoline-modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degeneration.
1/2021Model studies of advanced glycation end product modification of heterograft biomaterials: The effects of in vitro glucose, glyoxal, and serum albumin on collagen structure and mechanical properties.
1/2019Drug-associated valvular heart diseases and serotonin-related pathways: a meta-analysis.
7/2017Serotonin and catecholamines in the development and progression of heart valve diseases.
5/2017Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction.
9/2009Fenfluramine disrupts the mitral valve interstitial cell response to serotonin.
2/2007Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate.
12/2005Site specific gene delivery in the cardiovascular system.
12/2002Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
12/2002Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert J Levy Research Topics

Disease

10Heart Valve Diseases (Valvular Heart Disease)
01/2022 - 12/2002
7Thrombosis (Thrombus)
11/2022 - 05/2002
5Inflammation (Inflammations)
12/2023 - 09/2002
4Carcinoid Tumor (Carcinoid)
05/2020 - 12/2002
3Aortic Valve Stenosis (Aortic Stenosis)
01/2020 - 02/2003
3Aortic Valve Disease
01/2020 - 11/2004
3Sclerosis
01/2020 - 02/2013
3Neoplasms (Cancer)
05/2015 - 01/2014
3Calcinosis
04/2010 - 03/2003
2Pathologic Constriction (Stenosis)
01/2024 - 10/2018
2Mitral Valve Insufficiency (Mitral Regurgitation)
01/2023 - 01/2018
2Neuroblastoma
05/2015 - 05/2015
2Cardiovascular Diseases (Cardiovascular Disease)
08/2010 - 03/2010
2Vascular Diseases (Vascular Disease)
05/2010 - 12/2005
2Cardiac Arrhythmias (Arrythmia)
12/2005 - 06/2003
1Neointima
01/2024
1Hypercholesterolemia
12/2023
1Coronary Disease (Coronary Heart Disease)
01/2022
1Parkinson Disease (Parkinson's Disease)
07/2017
1Diabetes Mellitus
05/2017
1Foreign Bodies (Foreign Body)
09/2014
1Pneumonia (Pneumonitis)
04/2014
1Pulmonary Edema
04/2014
1Lung Injury
04/2014
1Vascular Malformations
06/2012
1Heart Diseases (Heart Disease)
01/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2006
1Long QT Syndrome
06/2003

Drug/Important Bio-Agent (IBA)

6Serotonin (5 Hydroxytryptamine)IBA
05/2020 - 12/2002
5Glutaral (Glutaraldehyde)IBA
01/2022 - 02/2007
4Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2002
3EnzymesIBA
04/2014 - 08/2010
3AntioxidantsIBA
04/2014 - 08/2010
3Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2007 - 12/2002
2Peptides (Polypeptides)IBA
12/2023 - 12/2002
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2023 - 01/2006
2MetalsIBA
12/2020 - 01/2020
2Dopamine Agonists (Dopamine Agonist)IBA
01/2019 - 07/2017
2Appetite Depressants (Anorectics)IBA
01/2019 - 07/2017
2FenfluramineIBA
07/2017 - 09/2009
2Irinotecan (Camptosar)FDA LinkGeneric
05/2015 - 05/2015
2ProdrugsIBA
05/2015 - 05/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2014 - 02/2013
2CytokinesIBA
09/2014 - 04/2014
2CatalaseIBA
04/2014 - 02/2013
2Superoxide DismutaseIBA
04/2014 - 02/2013
1Paclitaxel (Taxol)FDA LinkGeneric
01/2024
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2020
1Serotonin AgentsIBA
05/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1OsteopontinIBA
01/2020
1OsteoprotegerinIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1PorphyrinsIBA
10/2018
1CollagenIBA
10/2018
1Serotonin ReceptorsIBA
01/2018
1Phentermine (Adipex-P)FDA LinkGeneric
07/2017
1CatecholaminesIBA
07/2017
1FibrinIBA
05/2016
1alpha-TocopherolFDA Link
05/2015
1Blood Proteins (Serum Proteins)IBA
09/2014
1Reactive Nitrogen SpeciesIBA
09/2014
1Immunoglobulin G (IgG)IBA
04/2014
1EndotoxinsIBA
04/2014
1Diphosphonates (Bisphosphonates)IBA
04/2010
1Epoxy Compounds (Epoxides)IBA
04/2010
1Collagenases (Collagenase)FDA Link
04/2010
1triglycidylamineIBA
04/2010
1Recombinant DNA (Recombinant DNA Research)IBA
03/2010
1Alkaline PhosphataseIBA
03/2007
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2007
1Polyurethanes (Polyurethane)IBA
01/2006
1CholesterolIBA
01/2006
1Transcription Factors (Transcription Factor)IBA
11/2004
1Potassium Channels (Potassium Channel)IBA
06/2003
1Ion Channels (Ion Channel)IBA
06/2003
1PotassiumIBA
06/2003
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
12/2002
1Transforming Growth Factor beta (TGF-beta)IBA
12/2002
1Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
12/2002
1GTP-Binding Proteins (G-Protein)IBA
12/2002
1Matrix Metalloproteinases (MMPs)IBA
09/2002
1Microfilament Proteins (Actin Binding Proteins)IBA
09/2002
1thymosin beta(4)IBA
09/2002
1PlatinumIBA
05/2002

Therapy/Procedure

11Stents
01/2024 - 12/2005
4Therapeutics
01/2022 - 06/2003
2Drug-Eluting Stents
12/2020 - 01/2020
2Bioprosthesis
02/2007 - 03/2003
1Percutaneous Coronary Intervention
01/2022
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2017
1Aftercare (After-Treatment)
05/2015
1Intravenous Injections
04/2014
1Heart Valve Prosthesis
01/2006